ETON·29772L108·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
ETON (ETON PHARMACEUTICALS INC) is held by 61 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($42.4M), GEODE CAPITAL MANAGEMENT, LLC ($14.3M), STATE STREET CORP ($13.1M). Net institutional sentiment: Mixed.
See how ETON's score breaks down across 4 SEC sources
Showing 1-20 of 71
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer